Diuretic Titration in Worsening Heart Failure with Worsening Renal Function
A 72-year-old man with heart failure with reduced ejection fraction (EF 30%) is admitted with 4+ lower extremity edema, orthopnea, jugular venous distension to the jaw, and 6 kg weight gain over two weeks. He takes guideline-directed medical therapy including sacubitril/valsartan, carvedilol, spironolactone, and furosemide 40 mg daily. On admission, creatinine rises from a baseline of 1.3 to 1.9 mg/dL after two days of intravenous furosemide 80 mg twice daily, and his urine output is 1.2 L/day. He remains dyspneic and edematous. The admitting team debates stopping the diuretic because 'the kidneys are worsening.'
1. How should you interpret the rise in creatinine in this context, and what is the appropriate response?
Read the worked answer
A rise in creatinine during aggressive decongestion is common and often reflects hemodynamic changes (reduced renal perfusion pressure from intravascular volume depletion or venous congestion) rather than true tubular injury. In the setting of persistent congestion-elevated JVP, edema, orthopnea-the priority is decongestion, and a modest creatinine rise is often tolerated if the patient is not hypotensive and remains congested. Stopping the diuretic prematurely leaves the patient volume-overloaded, which itself worsens renal function and outcomes. The appropriate response is to reassess volume status carefully, ensure adequate diuresis (consider a higher dose or a different strategy), monitor electrolytes and renal function, and avoid reflexively discontinuing therapy. Distinguish this from true acute kidney injury with oliguria or hemodynamic instability, which would require a different approach.
2. What strategies can improve diuresis while limiting further renal deterioration?
Read the worked answer
Options include escalating loop diuretic dose to overcome diuretic resistance, adding a thiazide-like diuretic (metolazone) for sequential nephron blockade, or considering intravenous bumetanide if furosemide response is inadequate. Ensure the patient is not hypotensive; if blood pressure allows, continue guideline-directed therapy. Avoid nephrotoxins (NSAIDs, contrast). Monitor daily weights, input/output, electrolytes (especially potassium and magnesium), and renal function. If he remains congested despite escalation, consider ultrafiltration or inotropic support in a monitored setting. The key judgment is that worsening congestion is more dangerous than a modest creatinine bump.
3. What should happen to his chronic heart failure medications during this admission?
Read the worked answer
Continue guideline-directed medical therapy unless there is a compelling reason to hold it (e.g., symptomatic hypotension, hyperkalemia, or severe renal dysfunction). Sacubitril/valsartan and carvedilol should generally be continued if he is stable hemodynamically; spironolactone may need to be held if potassium rises or renal function worsens significantly, but it should be restarted when stable. The priority is decongestion, then optimization. Do not stop all heart failure medications simply because creatinine rose; that can precipitate decompensation. Reassess after decongestion and plan for close outpatient follow-up with repeat labs.